Search by Drug Name or NDC

    NDC 68047-0129-16 LoHist DM 2; 10; 5 mg/5mL; mg/5mL; mg/5mL Details

    LoHist DM 2; 10; 5 mg/5mL; mg/5mL; mg/5mL

    LoHist DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 68047-0129
    Product ID 68047-129_099353c9-371a-29cc-e063-6394a90a5bf3
    Associated GPIs 43995803081220
    GCN Sequence Number 050001
    GCN Sequence Number Description brompheniram/phenylephrine/DM LIQUID 2-5-10MG/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 15847
    HICL Sequence Number 035368
    HICL Sequence Number Description BROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name LoHist DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 2; 10; 5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Larken Laboratories, Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 68047-0129-16 (68047012916)

    NDC Package Code 68047-129-16
    Billing NDC 68047012916
    Package 473 mL in 1 BOTTLE (68047-129-16)
    Marketing Start Date 2012-06-01
    NDC Exclude Flag N
    Pricing Information N/A